Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
Emergence Therapeutics has raised €87M across 1 funding round from 1 investor, most recently a round in Dec 2021. Based in Duisburg, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-07 | Other | €87M |
| Pontifax Venture Capital |
| View deal → |
